National Cancer Institute Clinical Trials Program in colorectal cancer

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 42, Issue , 1998, Pages

  Conley, Barbara A ^a   Kaplan, Richard S ^a   Arbuck, Susan G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Adjuvant therapy; Chemotherapy; Clinical trials; Colon cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; TEGAFUR; URACIL;

ADJUVANT THERAPY; CANCER STAGING; CHEMOTHERAPY; COLON CANCER; CONFERENCE PAPER; HUMAN; METASTASIS; PRIORITY JOURNAL;

EID: 0031720459     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051084     Document Type: Conference Paper

References (15)

1. Buyse M, Zeneniuch-Jacquotte A, Chalmers TC (1988) Adjuvant therapy for colorectal cancer, why we still don't know. JAMA 259:3571
2. Erlichman C, Svingen PA, Mullany SA Kaufman SH (1996) Synergistic interaction of SN-38 and 5FU/leucovorin. Proc Am Assoc Cancer Res 37:a1999
3. Haller DG, Catalano PJ, Macdonald JS Mayer RJ (1997) Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: four year results of INT-0089. Proc Am Soc Clin Oncol 16:265a
4. Kemeny N (1996) Colorectal cancer - an undertreated disease. AntiCancer Drugs 7:623
5. Mamounas EP, Rockette H, Jones J, Wieand S, Wickerham DL, Fisher B, Wolmark N (1996) Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B vs. Dukes' C colon cancer: results from four NSABP adjuvant studies. Proc Am Soc Clin Oncol 15:205
6. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Weeder MH, Maillard JA (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon cancer: a final report. Ann Intern Med 122:321
7. NIH Consensus Conference, 1990 (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444
8. O'Connell MJ, Laurie JA, Shepherd L, Kahn MJ, Pazdur R, Fitzgibbons RJ, Erlichman C, Wieand HS (1996) A prospective evaluation of chemotherapy duration and regimen as surgical adjuvant treatment for high-risk colon cancer: a collaborative trial of the North Central Cancer Treatment Group and the National Cancer Institute of Canada Clinical Trials Group. Proc Am Soc Clin Oncol 15:209
9. O'Connell MJ, Laurie JA, Kahn M, Fitzgibbons RJ Jr, Erlichmann C, Shepherd L, Moertel CG, Kocha WI, Pazdur R, Wieand HS, Rubin J, Vukov AM, Donohue JH, Krook JE, Figueredo A (1998) Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 16:295
10. Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics, 1997. CA Cancer J Clin 47:5
11. Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, Buggisch P, Witle J, and the German Cancer Aid 17-1A Study Group (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 343:1177
12. Tepper JE, O'Connell MJ, Petroni GR, Hollis D, Cooke E, Benson AB III, Cummings B, Gunderson LL, Macdonald JS, Martenson JA (1997) Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol 15:2030
13. The Meta-analysis Group in Cancer (1998) Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16:301
14. Wolmark N, Fisher B, Rockette H, Redmond C, Wickerham DL, Fisher ER, Jones J, Glass A, Lerner H, Lawrence W, Prager D, Wexler M, Evans J, Cruz A, Dimitrov N, Jochimson P (1988) Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst 80:30
15. Wolmark N, Rockette H, Mamounas EP, Jones J, Petrelli N, Atkins J, Dimitrov N, Pugh R, Wickerham DL, Wieand S, Fisher B (1996) The relative efficacy of 5FU and leucovorin (FU-LV), 5FU and levamisole (FU-LEV), and 5FU and leucovorin and levamisole (FU-LV-LEV) in patients with Dukes' B and C carcinoma of the colon. First report of NSABP C-04. Proc Am Soc Clin Oncol 15:205